609 – Results from a Multicenter, Phase Ii, Open-Label, Nonrandomized Study of Ms1819 Spray Dried, a Recombinant Lipase for the Treatment of Exocrine Pancreatic Insufficiency in Patients with Chronic Pancreatitis

Authors :: P. Jaïs
Mathieu Schue
Nam Q. Nguyen
Luc Lebreton
Thijs Spoor
Gary S. Smith
Source :: Gastroenterology. 156:S-124
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: medicine.medical_specialty
Spray dried
Hepatology
biology
business.industry
Gastroenterology
medicine.disease
law.invention
law
Internal medicine
medicine
biology.protein
Recombinant DNA
Pancreatitis
In patient
Lipase
Open label
Exocrine pancreatic insufficiency
business

Full Text Access

Tools